News

Vect-Horus

VECT-HORUS raises 2.5 M€ to finance its development projects in the “targeted therapy” field

Marseille, 22 Mars 2017 - The French biotechnology start up VECT-HORUS, a European leader in the design of vectors that facilitate the delivery of drugs into the brain and other organs, announces completion of a new fund raising round for 2.5 million euros, from private shareholders including Société de Capital Risque (SCR) Provençale et Corse, a wholly owned subsidiary of Banque Populaire Méditerranée (BPMed). Since its creation, VECT-HORUS raised over 17 M€, including 6 M€ in grants and research tax credit.